TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.10
+4.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 40.33x
- P/S forward
- 4.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 47.94x
- Price / sales
- 6.97x
- Price / cash flow
- -10.72x
Enterprise value
- Enterprise value
- $302.2M
- EV / sales
- 6.70x
- EV / EBITDA
- -13.95x
- EV / EBIT
- -9.90x
- Market cap
- $314.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026